litlas
Log inCreate account

S. Eva Singletary

Active 1987–2010

Also published as
S.Eva Singletary
111
Papers
25,369
Citations
93
h-index
111
i10-index

Citations

Citations per year for S. Eva Singletary1974: 1 citations1980: 2 citations1982: 1 citations1989: 8 citations1990: 2 citations1991: 9 citations1992: 7 citations1993: 5 citations1994: 9 citations1995: 6 citations1996: 20 citations1997: 16 citations1998: 28 citations1999: 39 citations2000: 56 citations2001: 87 citations2002: 144 citations2003: 176 citations2004: 203 citations2005: 292 citations2006: 247 citations2007: 285 citations2008: 269 citations2009: 225 citations2010: 270 citations2011: 253 citations2012: 187 citations2013: 170 citations2014: 152 citations2015: 167 citations2016: 148 citations2017: 130 citations2018: 100 citations2019: 379 citations2020: 329 citations2021: 283 citations2022: 203 citations2023: 123 citations2024: 181 citations2025: 74 citations1975–1979: no citations, so these years are not shown1981: no citations, so this year is not shown1983–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,221 citing papers, 37% of this breakdownUnited Kingdom: 398 citing papers, 6.6% of this breakdownChina: 315 citing papers, 5.2% of this breakdownItaly: 281 citing papers, 4.7% of this breakdownFrance: 235 citing papers, 3.9% of this breakdownGermany: 231 citing papers, 3.8% of this breakdownCanada: 224 citing papers, 3.7% of this breakdownNetherlands: 209 citing papers, 3.5% of this breakdownSouth Korea: 138 citing papers, 2.3% of this breakdownSpain: 137 citing papers, 2.3% of this breakdownSwitzerland: 130 citing papers, 2.2% of this breakdownAustralia: 120 citing papers, 2% of this breakdown
0%37%Other 22.8%

Institutions

Fields

  • Medicine46.4%
  • Biochemistry, Genetics and Molecular Biology44.2%
  • Engineering2.1%
  • Health Professions2.1%
  • Computer Science1.6%
  • Immunology and Microbiology0.7%
  • Other2.9%

Topics

  • Breast Cancer Treatment Studies17.4%
  • Breast Lesions and Carcinomas9.5%
  • Breast Implant and Reconstruction6.6%
  • HER2/EGFR in Cancer Research4%
  • Cancer Treatment and Pharmacology2.2%
  • Medical Imaging Techniques and Applications1.9%
  • Other58.4%

Coauthors

All papers

Open in search
  1. Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

    Authors: W. Fraser Symmans, Florentia Peintinger, Christos Hatzis, Radhika Rajan, Henry M. Kuerer, Vicente Valero, Lina Assad, Anna W. Poniecka, Bryan T. Hennessy, Marjorie Green, Aman U. Buzdar, S. Eva Singletary, Gabriel N. Hortobágyi, Lajos Pusztai - Journal of Clinical Oncology 2007 cited by 1,662

  2. Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

    Authors: Henry M. Kuerer, Lisa A. Newman, Terry L. Smith, Fred C. Ames, Kelly K. Hunt, Kapil Dhingra, Richard L. Theriault, Gurpreet Singh, Susan M. Binkley, Nour Sneige, Thomas A. Buchholz, Merrick I. Ross, Marsha D. McNeese, Aman U. Buzdar, Gabriel N. Hortobágyi, S. Eva Singletary - Journal of Clinical Oncology 1999 cited by 1,337

  3. Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy

    Authors: Bryan T. Hennessy, Gabriel N. Hortobágyi, Roman Rouzier, Henry M. Kuerer, Nour Sneige, Aman U. Buzdar, Shu Wan Kau, Bruno D. Fornage, Ayşegül A. Şahin, Kristine Broglio, S. Eva Singletary, Vicente Valero - Journal of Clinical Oncology 2005 cited by 422

  4. Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

    Authors: Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis, Daniel J. Booser, Eva Thomas, Richard L. Theriault, Lajos Pusztai, Marjorie C. Green, Banu Arun, Sharon H. Giordano, Massimo Cristofanilli, Debra Frye, Terry L. Smith, Kelly K. Hunt, S. Eva Singletary, Ayşegül A. Şahin, Michael S. Ewer, Thomas A. Buchholz, Donald A. Berry, Gabriel N. Hortobágyi - Journal of Clinical Oncology 2005 cited by 1,170

  5. Impact of Preoperative Versus Postoperative Chemotherapy on the Extent and Number of Surgical Procedures in Patients Treated in Randomized Clinical Trials for Breast Cancer

    Authors: Judy C. Boughey, Florentia Peintinger, Funda Meric‐Bernstam, Allison Perry, Kelly K. Hunt, Gildy V. Babiera, S. Eva Singletary, Isabelle Bedrosian, Anthony Lucci, Aman U. Buzdar, Lajos Pusztai, Henry M. Kuerer - Annals of Surgery 2006 cited by 168

  6. Incidence and Impact of Documented Eradication of Breast Cancer Axillary Lymph Node Metastases Before Surgery in Patients Treated With Neoadjuvant Chemotherapy

    Authors: Henry M. Kuerer, Ayşegül A. Şahin, Kelly K. Hunt, Lisa A. Newman, Tara M. Breslin, Fred C. Ames, Merrick I. Ross, Aman U. Buzdar, Gabriel N. Hortobagyi, S. Eva Singletary - Annals of Surgery 1999 cited by 358

  7. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy

    Authors: S. Eva Singletary - The American Journal of Surgery 2002 cited by 613

  8. Positive surgical margins and ipsilateral breast tumor recurrence predict disease‐specific survival after breast‐conserving therapy

    Authors: Funda Meric, Nadeem Q. Mirza, Georges Vlastos, Thomas A. Buchholz, Henry M. Kuerer, Gildy V. Babiera, S. Eva Singletary, Merrick I. Ross, Frederick C. Ames, Barry W. Feig, Savitri Krishnamurthy, George H. Perkins, Marsha D. McNeese, Eric A. Strom, Vicente Valero, Kelly K. Hunt - Cancer 2003 cited by 197

  9. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer

    Authors: Jennifer F. Tseng, Steven J. Kronowitz, Charlotte C. Sun, Allison Perry, Kelly K. Hunt, Gildy V. Babiera, Lisa A. Newman, S. Eva Singletary, Nadeem Q. Mirza, Frederick C. Ames, Funda Meric‐Bernstam, Merrick I. Ross, Barry W. Feig, Geoffrey L. Robb, Henry M. Kuerer - Cancer 2004 cited by 151

  10. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

    Authors: S. Eva Singletary, Craig Allred, Pandora Ashley, Lawrence W. Bassett, Donald A. Berry, Kirby I. Bland, Patrick I. Borgen, Gary M. Clark, Stephen B. Edge, Daniel F. Hayes, Lorie L. Hughes, R. V. P. Hutter, Monica Morrow, David L. Page, Abram Recht, Richard L. Theriault, Ann D. Thor, Donald L. Weaver, H. Samuel Wieand, Frederick L. Greene - Journal of Clinical Oncology 2002 cited by 1,183

  11. Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology

    Authors: Mary Richardson, Tina Sanders, J. Lynn Palmer, Anthony Greisinger, S. Eva Singletary - Journal of Clinical Oncology 2000 cited by 1,026

  12. Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen

    Authors: Aman U. Buzdar, Vicente Valero, Nuhad K. Ibrahim, Deborah Francis, Kristine Broglio, Richard L. Theriault, Lajos Pusztai, Marjorie C. Green, S. Eva Singletary, Kelly K. Hunt, Ayşegül A. Şahin, Francisco J. Esteva, W. Fraser Symmans, Michael S. Ewer, Thomas A. Buchholz, Gabriel N. Hortobágyi - Clinical Cancer Research 2007 cited by 469

  13. Rating the Risk Factors for Breast Cancer

    Authors: S. Eva Singletary - Annals of Surgery 2003 cited by 360

  14. Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma

    Authors: Monica Morrow, E. A. Strom, L W Bassett, D. David Dershaw, Barbara Fowble, A E Giuliano, Jay R. Harris, F. O’Malley, Stuart J. Schnitt, S. Eva Singletary, David P. Winchester - CA A Cancer Journal for Clinicians 2002 cited by 322

  15. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

    Authors: S. Eva Singletary, Craig Allred, Pandora Ashley, Lawrence W. Bassett, Donald A. Berry, Kirby I. Bland, Patrick I. Borgen, Gary M. Clark, Stephen B. Edge, Daniel F. Hayes, Lorie L. Hughes, R. V. P. Hutter, Monica Morrow, David L. Page, Abram Recht, Richard L. Theriault, Ann D. Thor, Donald L. Weaver, H. Samuel Wieand, Frederick L. Greene - Surgical Clinics of North America 2003 cited by 294

  16. Inflammatory breast cancer (IBC) and patterns of recurrence

    Authors: Massimo Cristofanilli, Vicente Valero, Aman U. Buzdar, Shu‐Wan Kau, Kristine Broglio, Ana M. González-Angulo, Nour Sneige, Rabiul Islam, Naoto T. Ueno, Thomas A. Buchholz, S. Eva Singletary, Gabriel N. Hortobágyi - Cancer 2007 cited by 209

  17. Incidence, Time Course, and Determinants of Menstrual Bleeding After Breast Cancer Treatment: A Prospective Study

    Authors: Jeanne A. Petrek, Michelle J. Naughton, L. Douglas Case, Electra D. Paskett, Elizabeth Z. Naftalis, S. Eva Singletary, Paniti Sukumvanich - Journal of Clinical Oncology 2006 cited by 433

  18. Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging Manual

    Authors: S. Eva Singletary, James L. Connolly - CA A Cancer Journal for Clinicians 2006 cited by 399

  19. Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative Irradiation

    Authors: Angela Katz, Eric A. Strom, Thomas A. Buchholz, Howard D. Thames, Cynthia D. Smith, Anuja Jhingran, Gabriel N. Hortobágyi, Aman U. Buzdar, Richard L. Theriault, S. Eva Singletary, Marsha D. McNeese - Journal of Clinical Oncology 2000 cited by 388

  20. Classifying local disease recurrences after breast conservation therapy based on location and histology

    Authors: Eugene Huang, Thomas A. Buchholz, Funda Meric, Savitri Krishnamurthy, Nadeem Q. Mirza, Frederick C. Ames, Barry W. Feig, Henry M. Kuerer, Merrick I. Ross, S. Eva Singletary, Marsha D. McNeese, Eric A. Strom, Kelly K. Hunt - Cancer 2002 cited by 254

  21. Role for Intraoperative Margin Assessment in Patients Undergoing Breast-Conserving Surgery

    Authors: Neslihan Cabıoğlu, Kelly K. Hunt, Ayşegül A. Şahin, Henry M. Kuerer, Gildy V. Babiera, S. Eva Singletary, Gary J. Whitman, Merrick I. Ross, Frederick C. Ames, Barry W. Feig, Thomas A. Buchholz, Funda Meric‐Bernstam - Annals of Surgical Oncology 2007 cited by 251

  22. Small (≤2-cm) Breast Cancer Treated with US-guided Radiofrequency Ablation: Feasibility Study

    Authors: Bruno D. Fornage, Nour Sneige, Merrick I. Ross, Attiqa N. Mirza, Henry M. Kuerer, Beth S. Edeiken, Frederick C. Ames, Lisa A. Newman, Gildy V. Babiera, S. Eva Singletary - Radiology 2004 cited by 225

  23. Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center Experience

    Authors: Allen Chen, Funda Meric‐Bernstam, Kelly K. Hunt, Howard D. Thames, Mary Jane Oswald, Elesyia D. Outlaw, Eric A. Strom, Marsha D. McNeese, Henry M. Kuerer, Merrick I. Ross, S. Eva Singletary, Fredrick C. Ames, Barry W. Feig, Ayşegül A. Şahin, George H. Perkins, Naomi R. Schechter, Gabriel N. Hortobágyi, Thomas A. Buchholz - Journal of Clinical Oncology 2004 cited by 410

  24. Career Satisfaction, Practice Patterns and Burnout among Surgical Oncologists: Report on the Quality of Life of Members of the Society of Surgical Oncology

    Authors: Henry M. Kuerer, Timothy J. Eberlein, Raphael E. Pollock, Mashele Huschka, Walter F. Baile, Monica Morrow, Fabrizio Michelassi, S. Eva Singletary, Paul J. Novotny, Jeff A. Sloan, Tait D. Shanafelt - Annals of Surgical Oncology 2007 cited by 307